Causal relationships between allergic diseases and significant declines in lung function: a multivariable Mendelian randomization study by Jiannan Lin (6954983)

“…We rigorously selected instrumental variables (IVs) based on established criteria and employed both univariable and multivariable MR approaches to investigate the relationship between various allergic diseases and significant declines in lung function.…”

<b>Nest mass in forest tits </b><b><i>Paridae</i></b><b> </b><b>increases with elevation and decreasing body mass, promoting reproductive success</b> by Clara Wild (19246606)

“…Nest boxes were installed along an elevational gradient of approximately 1000 m a.sl., either in forest gaps with fluctuating microclimatic conditions or in closed forests with buffered microclimates. We found that nest mass increased by ~ 60% along the elevational gradient, but the effect of canopy openness on nest mass was not significant, while nest mass decreased along the ranked species from the smallest <i>Periparus ater</i> to the medium-sized <i>Cyanistes caeruleus</i> and the largest <i>Parus major</i>. …”

Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

summary of the confidence intervals. by Yohannis Derbew Molla (16471771)

Subjects:

PRISMA flowchart of the study selection process. by Yohannis Derbew Molla (16471771)

Subjects:

Suggestive significant associations in the candidate gene approach. by Dai Nogimura (21445649)

Subjects:

Volcano plot on differential expression. by Bingshuo Shi (21485387)

Subjects:

Join-point regression analysis of the statistically significant linear increase in use of anxiolytics, psychostimulants and noot ropic drugs, sedatives and hypnotics, gabapentinoid... by Jelena Filimonovic (22305307)

Subjects:

ECoG timescales decrease during spatial attention. by Isabel Raposo (21615517)

Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque count. by Francesca Catto (21253435)

Flowchart of included and excluded patients. by P.G.J. ter Horst (21743830)

Subjects:

Characteristics of the study group. by P.G.J. ter Horst (21743830)

Subjects:

Study variables. by Amit Timilsina (15203538)

Subjects:

Descriptive statistics. by Amit Timilsina (15203538)

Subjects:

This is the raw data used for this study. by James M. Friedman (22522150)

“…Average age was 48. 37% were male. 89% of patients who received a preoperative subcoracoid injection reported a significant decrease in presenting symptoms. 6 months after PM release, median VAS pain scores decreased from 8 to 2. …”

Pre-operative versus post-operative symptoms. by James M. Friedman (22522150)

“…Average age was 48. 37% were male. 89% of patients who received a preoperative subcoracoid injection reported a significant decrease in presenting symptoms. 6 months after PM release, median VAS pain scores decreased from 8 to 2. …”

Patient Demographics. by James M. Friedman (22522150)

“…Average age was 48. 37% were male. 89% of patients who received a preoperative subcoracoid injection reported a significant decrease in presenting symptoms. 6 months after PM release, median VAS pain scores decreased from 8 to 2. …”

Diagnostic Criteria for Human Disharmony Loop. by James M. Friedman (22522150)

“…Average age was 48. 37% were male. 89% of patients who received a preoperative subcoracoid injection reported a significant decrease in presenting symptoms. 6 months after PM release, median VAS pain scores decreased from 8 to 2. …”

Group-based descriptive statistics and effect sizes. by Murat Tutar (22250461)

Subjects:

Comparison of questionnaire scores among genotypes for the significant associations. by Dai Nogimura (21445649)

Subjects: